Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hypertension is a condition that develops when your blood pressure is too high. An antihypertensive is a drug used to treat high blood pressure.
The report presented by Global Market Monitor provides a detailed analysis of the various factors driving the growth of the global Antihypertensive Drugs market. This report describes the range of different sectors and applications that could potentially impact the future market and provides a yield analysis of the global Antihypertensive Drugs market over the forecast period. The increasing prevalence of diabetes increases the risk of developing high blood pressure. Therefore, the increase in the number of people with these risk factors is expected to increase the number of people with hypertension. In turn, this is expected to facilitate the use of existing drugs, which will drive growth in the global antihypertensive drug market over the forecast period. Generic drugs, however, contain the same active ingredient in the same amount as the brand name drug. Generic drug development is simple and less time-consuming. This may hinder the growth of Antihypertensive Drugs market. Antihypertensive Drugs Market is projected to grow at a CAGR of 5% from 2020 to 2026.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antihypertensive Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antihypertensive Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antihypertensive Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Takeda
Pfizer
Merck
Astra Zeneca
Lupin
United Therapeutics
Daiichi Sankyo
Sanofi
Johnson & Johnson
Ranbaxy Laboratories
Novartis
Actelion
By Type:
ARB
CCB
Other
By End-User:
Hypertension
PAH
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antihypertensive Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antihypertensive Drugs Market Size and Growth Rate of ARB from 2016 to 2027
-
1.3.2 USA Antihypertensive Drugs Market Size and Growth Rate of CCB from 2016 to 2027
-
1.3.3 USA Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antihypertensive Drugs Market Size and Growth Rate of Hypertension from 2016 to 2027
-
1.4.2 USA Antihypertensive Drugs Market Size and Growth Rate of PAH from 2016 to 2027
-
1.4.3 USA Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antihypertensive Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antihypertensive Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of ARB
-
3.4.2 Market Size and Growth Rate of CCB
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Antihypertensive Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antihypertensive Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antihypertensive Drugs in Hypertension
-
4.4.2 Market Size and Growth Rate of Antihypertensive Drugs in PAH
-
4.4.3 Market Size and Growth Rate of Antihypertensive Drugs in Other
5 Market Analysis by Regions
-
5.1 USA Antihypertensive Drugs Production Analysis by Regions
-
5.2 USA Antihypertensive Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antihypertensive Drugs Landscape Analysis
-
6.1 West USA Antihypertensive Drugs Landscape Analysis by Major Types
-
6.2 West USA Antihypertensive Drugs Landscape Analysis by Major End-Users
7 South USA Antihypertensive Drugs Landscape Analysis
-
7.1 South USA Antihypertensive Drugs Landscape Analysis by Major Types
-
7.2 South USA Antihypertensive Drugs Landscape Analysis by Major End-Users
8 Middle West USA Antihypertensive Drugs Landscape Analysis
-
8.1 Middle West USA Antihypertensive Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Antihypertensive Drugs Landscape Analysis by Major End-Users
9 Northeast USA Antihypertensive Drugs Landscape Analysis
-
9.1 Northeast USA Antihypertensive Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Antihypertensive Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Takeda
-
10.1.1 Takeda Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Pfizer
-
10.2.1 Pfizer Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Merck
-
10.3.1 Merck Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Astra Zeneca
-
10.4.1 Astra Zeneca Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Lupin
-
10.5.1 Lupin Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 United Therapeutics
-
10.6.1 United Therapeutics Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Daiichi Sankyo
-
10.7.1 Daiichi Sankyo Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sanofi
-
10.8.1 Sanofi Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Johnson & Johnson
-
10.9.1 Johnson & Johnson Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Ranbaxy Laboratories
-
10.10.1 Ranbaxy Laboratories Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Novartis
-
10.11.1 Novartis Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Actelion
-
10.12.1 Actelion Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of ARB from 2016 to 2027
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of CCB from 2016 to 2027
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of Hypertension from 2016 to 2027
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of PAH from 2016 to 2027
-
Figure USA Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antihypertensive Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antihypertensive Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antihypertensive Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Antihypertensive Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of ARB
-
Figure Market Size and Growth Rate of CCB
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antihypertensive Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antihypertensive Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hypertension
-
Figure Market Size and Growth Rate of PAH
-
Figure Market Size and Growth Rate of Other
-
Table USA Antihypertensive Drugs Production by Regions
-
Table USA Antihypertensive Drugs Production Share by Regions
-
Figure USA Antihypertensive Drugs Production Share by Regions in 2016
-
Figure USA Antihypertensive Drugs Production Share by Regions in 2021
-
Figure USA Antihypertensive Drugs Production Share by Regions in 2027
-
Table USA Antihypertensive Drugs Consumption by Regions
-
Table USA Antihypertensive Drugs Consumption Share by Regions
-
Figure USA Antihypertensive Drugs Consumption Share by Regions in 2016
-
Figure USA Antihypertensive Drugs Consumption Share by Regions in 2021
-
Figure USA Antihypertensive Drugs Consumption Share by Regions in 2027
-
Table West USA Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table West USA Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure West USA Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure West USA Antihypertensive Drugs Consumption Share by Types in 2027
-
Table West USA Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure West USA Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure West USA Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table South USA Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table South USA Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure South USA Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure South USA Antihypertensive Drugs Consumption Share by Types in 2027
-
Table South USA Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure South USA Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure South USA Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Middle West USA Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Northeast USA Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Astra Zeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zeneca
-
Figure Sales and Growth Rate Analysis of Astra Zeneca
-
Figure Revenue and Market Share Analysis of Astra Zeneca
-
Table Product and Service Introduction of Astra Zeneca
-
Table Company Profile and Development Status of Lupin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
-
Figure Sales and Growth Rate Analysis of Lupin
-
Figure Revenue and Market Share Analysis of Lupin
-
Table Product and Service Introduction of Lupin
-
Table Company Profile and Development Status of United Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Therapeutics
-
Figure Sales and Growth Rate Analysis of United Therapeutics
-
Figure Revenue and Market Share Analysis of United Therapeutics
-
Table Product and Service Introduction of United Therapeutics
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Ranbaxy Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ranbaxy Laboratories
-
Figure Sales and Growth Rate Analysis of Ranbaxy Laboratories
-
Figure Revenue and Market Share Analysis of Ranbaxy Laboratories
-
Table Product and Service Introduction of Ranbaxy Laboratories
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Actelion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actelion
-
Figure Sales and Growth Rate Analysis of Actelion
-
Figure Revenue and Market Share Analysis of Actelion
-
Table Product and Service Introduction of Actelion
-
